EUVIMEDEUVIMED entdecken
Klinische StudieOpen Access

Pilot study of a decision aid on BRCA1/2 genetic testing among Orthodox Jewish women

Meghna S Trivedi iD, Haley Manley, Haeseung Yi, Thomas Silverman, Wendy K Chung, Paul S Appelbaum, Rebecca Starck, Isaac Schecter, Rita Kukafka, Katherine D Crew

Familial Cancer · 2024

DOI: 10.1007/s10689-024-00371-6 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift Familial Cancer, 2024. Verfasst von Meghna S Trivedi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Vagelos College of Physicians and Surgeons, Columbia University, 161 Fort Washington Avenue HIP 10, New York, NY, 10032, USA.…. Hauptthemen laut MEDLINE: BRCA1 Protein, Breast Neoplasms, Decision Support Techniques, Genetic Testing. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, NCI NIH HHS, NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Orthodox Jewish women face unique social, cultural, and religious factors that may influence uptake of BRCA1/2 genetic testing. We examined the impact of a web-based decision aid (DA) on BRCA1/2 genetic testing intention/completion among Orthodox Jewish women. We conducted a single-arm pilot study among 50 Orthodox Jewish women who were given access to a web-based DA entitled RealRisks and administered serial surveys at baseline and 1 and 6 months after exposure to the DA. Descriptive statistics were conducted for baseline characteristics and study measures. Comparisons were made to assess changes in study measures over time. Fifty Orthodox Jewish women enrolled in the study with a mean age of 43.9 years (standard deviation [SD] 14.6), 70% Modern Orthodox, 2% with personal history of breast cancer, and 68% and 16% with a family history of breast or ovarian cancer, respectively. At baseline, 27 (54%) participants intended to complete genetic testing. Forty-three participants (86%) completed RealRisks and the 1-month survey and 38 (76%) completed the 6-month survey. There was a significant improvement in BRCA1/2 genetic testing knowledge and decrease in decisional conflict after exposure to the DA. At 1 month, only 20 (46.5%) completed or intended to complete genetic testing (p = 0.473 compared to baseline). While the DA improved genetic testing knowledge and reduced decisional conflict, genetic testing intention/completion did not increase over time. Future interventions should directly address barriers to BRCA1/2 genetic testing uptake and include input from leaders in the Orthodox Jewish community. GOV ID: NCT03624088 (8/7/18).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BRCA1 ProteinBreast NeoplasmsDecision Support TechniquesGenetic TestingJewsAdultFemaleHumansMiddle AgedBRCA2 ProteinGenes, BRCA1Genes, BRCA2Genetic Predisposition to DiseaseJudaismOvarian NeoplasmsPilot Projects

Stichwörter der Autor:innen

BRCA1/2Genetic testingOrthodox Jewish

Substanzen

BRCA1 ProteinBRCA1 protein, humanBRCA2 ProteinBRCA2 protein, human

Autor:innen und Institutionen

  • Department of Medicine, Vagelos College of Physicians and Surgeons, Columbia University, 161 Fort Washington Avenue HIP 10, New York, NY, 10032, USA. mst2134@cumc.columbia.edu.
  • College of Law, DePaul University, Chicago, IL, USA.
  • Department of Health and Behavior Studies, Teachers College, Columbia University, New York, NY, USA.
  • Department of Biomedical Informatics, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, USA.
  • Department of Pediatrics, Boston Children's Hospital, Boston, MA, USA.
  • Department of Psychiatry, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, USA.

ORCID-Profile: Meghna S Trivedi

Förderung

  • NIH HHS
  • NCI NIH HHS
  • NCATS NIH HHS
  • Susan G. Komen
  • National Institutes of Health

Zitieren

APA

Trivedi, M. S., Manley, H., Yi, H., Silverman, T., Chung, W. K., Appelbaum, P. S., Starck, R., Schecter, I., Kukafka, R., & Crew, K. D. (2024). Pilot study of a decision aid on BRCA1/2 genetic testing among Orthodox Jewish women. Familial Cancer. https://doi.org/10.1007/s10689-024-00371-6

Vancouver

Trivedi MS, Manley H, Yi H, Silverman T, Chung WK, Appelbaum PS, et al. Pilot study of a decision aid on BRCA1/2 genetic testing among Orthodox Jewish women. Familial Cancer. 2024. doi:10.1007/s10689-024-00371-6

BibTeX
@article{Trivedi2024,
  author = {Trivedi, Meghna S and Manley, Haley and Yi, Haeseung and Silverman, Thomas and Chung, Wendy K and Appelbaum, Paul S and Starck, Rebecca and Schecter, Isaac and Kukafka, Rita and Crew, Katherine D},
  title = {Pilot study of a decision aid on BRCA1/2 genetic testing among Orthodox Jewish women},
  journal = {Familial Cancer},
  year = {2024},
  doi = {10.1007/s10689-024-00371-6}
}
Kostenlos starten →